Table 6.
Comparison of the Mean Scores of IES-R, STAI-S, and STAI-T Among the Participants by Gender
| IES-R total | Intrusion | Avoidance | Hyperarousal | STAI-S | STAI-T | |
|---|---|---|---|---|---|---|
| I-CD (mean ± SD) | ||||||
| Male | 22.8 ± 13.2 | 6.9 ± 5.7 | 11.1 ± 5 | 4.9 ± 4.6 | 38.2 ± 11.4 | 43.4 ± 10.6 |
| Female | 24 ± 14.7 | 7.3 ± 6 | 11 ± 5.7 | 5.8 ± 5.2 | 40.9 ± 11.8 | 45.8 ± 10.5 |
| Total | 23.4 ± 13.9 | 7 ± 5.8 | 11 ± 5.3 | 5.3 ± 4.9 | 39.4 ± 11.6 | 44.4 ± 10.6 |
| t | 0.71 | 0.59 | −0.21 | 1.55 | 1.93 | 1.90 |
| II-UC (mean ± SD) | ||||||
| Male | 21.8 ± 15.9 | 6.7 ± 6.2 | 9.9 ± 6 | 5.1 ± 5.4 | 38.9 ± 13.3 | 43.1 ± 12.1 |
| Female | 26.9 ± 14.9 | 8.5 ± 6.4 | 11.8 ± 4.8 | 6.6 ± 5.7 | 39.9 ± 11.4 | 45.9 ± 11.1 |
| Total | 24.6 ± 15.6 | 7.66 ± 6.3 | 10.97 ± 5.4 | 5.9 ± 5.6 | 39.5 ± 12.3 | 44.6 ± 11.6 |
| t | 2.44* | 2.10* | 2.52* | 1.96 | 0.60 | 1.80 |
| III-controls (mean ± SD) | ||||||
| Male | 22.5 ± 13.1 | 7.2 ± 5.3 | 11.5 ± 5.6 | 3.8 ± 4.3 | 37.4 ± 10.2 | 38.9 ± 8.8 |
| Female | 27.5 ± 14.4 | 9.4 ± 6.1 | 12.3 ± 5.5 | 5.8 ± 5.1 | 41.4 ± 11.6 | 43.9 ± 10.2 |
| Total | 25.3 ± 14.0 | 8.4 ± 5.8 | 11.9 ± 5.5 | 4.9 ± 4.8 | 39.7 ± 11.2 | 41.7 ± 9.9 |
| t | 3.10** | 3.34** | 1.15 | 3.67** | 3.14** | 4.51** |
CD, Crohn’s disease; UC, ulcerative colitis; SD, standard deviation.
* P < .05; ** P < .01.
Post hoc analysis results (adjusted P value in Turkey correction).
Intrusion scores
Group I versus Group III, P < .05; Group I females versus Group III females, P < .05.
STAI-T scores
Group I versus Group III, P < .01; Group II versus Group III, P < .01; Group I males versus Group III males, P < .01; Group II males versus Group III males, P < .01.
The remaining P values did not show statistical significance.